[{"AccountsPayableCurrent_0_Q3_USD":1905000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":116000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":62903000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4245000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":131088000.0,"PaymentsForRepurchaseOfInitialPublicOffering_3_Q3_USD":3255000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-116000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-22000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":19000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1000.0,"OtherAssetsNoncurrent_0_Q3_USD":2670000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":258000.0,"OperatingLeaseExpense_3_Q3_USD":71000.0,"OperatingLeaseExpense_1_Q3_USD":21000.0,"OperatingIncomeLoss_3_Q3_USD":-27710000.0,"OperatingIncomeLoss_1_Q3_USD":-11720000.0,"OperatingExpenses_3_Q3_USD":27710000.0,"OperatingExpenses_1_Q3_USD":11720000.0,"NonoperatingIncomeExpense_3_Q3_USD":125000.0,"ProfitLoss_3_Q3_USD":-27585000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":7000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":8680000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":20551000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":0.0,"TemporaryEquitySharesIssued_0_Q3_shares":0.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0001,"TemporaryEquityLiquidationPreference_0_Q3_USD":0.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":93000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":0.0,"StockholdersEquity_0_Q3_USD":228364000.0,"ShortTermInvestments_0_Q3_USD":145144000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":3.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":9.66,"NonoperatingIncomeExpense_1_Q3_USD":50000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.006,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q3_pure":0.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.699,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q3_pure":0.667,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":1416000.0,"SaleOfStockPricePerShare_0_Q3_USD":20.03,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-97927000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":400000.0,"NetIncomeLoss_3_Q3_USD":-27585000.0,"NetIncomeLoss_1_Q3_USD":-11670000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-26472000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":6776757.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashEquivalentsAtCarryingValue_0_Q3_USD":84097000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":65943000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":85209000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":230400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":85209000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":25000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":229241000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":229241000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":229225000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":2000.0,"AssetsCurrent_0_Q3_USD":234598000.0,"Assets_0_Q3_USD":237275000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3117338.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":3117338.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":124000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":1416000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":663000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":663000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":326272000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":16000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":252000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":7006000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":18000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":26671511.0,"CommonStockSharesIssued_0_Q3_shares":33457029.0,"CommonStockValue_0_Q3_USD":3000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-68187000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":160602000.0,"LiabilitiesCurrent_0_Q3_USD":8911000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":237275000.0,"InvestmentsAndCash_0_Q3_USD":229241000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":241000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":72000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2980000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":1231000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":3280000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":501000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"CommonStockSharesOutstanding_0_Q3_shares":33457029.0,"IncomeTaxesPaid_3_Q3_USD":61000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":3040000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":6100000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":1585000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.85,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.44,"DividendsPayableCurrentAndNoncurrent_0_Q3_USD":0.0,"DepreciationDepletionAndAmortization_3_Q3_USD":3000.0,"ConversionOfStockAmountConverted1_3_Q3_USD":162612000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-27566000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-11671000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":7159000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":9688747.0,"Ticker":"IMGO","CIK":"1623715","name":"IMAGO BIOSCIENCES, INC.","OfficialName":"Imago BioSciences Inc. Common stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"606719826.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]